Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 April 2019 | Story Valentino Ndaba | Photo Valentino Ndaba
Andrew Lane
Mining the fourth industrial revolution way is the future says industry expert, Andrew Lane.

Innovation is imperative for the future of mining in South Africa. Industry expert, Andrew Lane proposes that leveraging on new information, mining technologies and energy knowhow, which are the hallmarks of the fourth industrial revolution, should set the scene for success.

Lane who is Africa Energy and Resource Leader at Deloitte, engaged students at a recent guest lecture hosted by the University of the Free State’s Business School on the Bloemfontein Campus. “The future is intelligent mining. It’s not just about technology; it’s about changing the way you do business,” he said.

Transforming traditional to trailblazing
“What gives you sustainable competitive advantage is the rate at which you innovate,” said Lane. Design paradigm shifts in the South African mining industry may have resulted in about 100 000 job losses during the past four years. However, mining companies stand to achieve significant gains through applying innovation.

Despite most of South Africa’s mines nearing the end of their lives, mining remains a large employer and investor attractor which ensures that the country holds a competitive advantage in the global economy. Lane is adamant that, “even though we have declined from 20% to 5% in terms of GDP contributions, mining remains a large contributor to export earnings”.

Reaching resource-rich regions
While some physical resources are inaccessible using current technology, “new mineral-processing technologies help tap into previously uneconomical mineral deposits”, according to Lane. In addition to the environment, 3D visualisation cameras can track employees and equipment in the bowels of the earth.

More mining, less loss
Integrating mining, energy, and information technology will ensure that companies reduce people, capital and energy intensity, while increasing mining intensity. The impossible can be achieved if technology is used well for developmental outcomes, employment, and improving standards of living.



News Archive

Haemophilia home infusion workshop
2017-12-17


 Description: haemophilia Tags: Haemophilia, community, patient, clinical skills, training 

Parents receive training for homecare of their children with haemophilia.
Photo Supplied


Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.” 

Clinical skills to empower parents and communities

There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.

The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.

A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept